Compare Enveric Biosciences Inc (ENVB) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while Direxion Daily Semiconductor Bear 3X Shares trades at $31.92 (market cap $1.89B). The key difference: Direxion Daily Semiconductor Bear 3X Shares is far larger — about 282.5× Enveric Biosciences Inc's market cap, and Direxion Daily Semiconductor Bear 3X Shares is more actively traded (66,118,733 versus 41,141). Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| ENVB | SOXS | |
|---|---|---|
Market Cap | $6.69M | $1.89B |
Volume | 41,141 | 66,118,733 |
Sector | Health | Leveraged / Inverse |
52-Week High | $10.80 | $988.00 |
52-Week Low | $1.27 | $29.62 |
Typical Hold Time | 14 Days | 11 Days |
Enterprise Value | -$1.60M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $30.645, up 3.43% today, reflecting its inverse leveraged exposure to semiconductor stocks. The technical outlook is bearish, with moving averages signaling strong selling pressure, while oscillators are neutral. Recent news highlights the fund's volatility and tactical use during semiconductor sector weakness, as seen in July 2026 when it surged on chip stock declines. A 1:10 stock split occurred on July 15, 2026, adjusting share structure.
The outlook for SOXS remains highly speculative, suited only for short-term traders betting against semiconductors. Key risks include the fund's decay from daily rebalancing, reliance on sector volatility, and persistent AI demand supporting chip stocks. Investors should avoid long-term holdings due to structural erosion and elevated loss potential in rising markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
